Encompass Health Corporation (NYSE: EHC) reported Q3 EPS of $0.78, $0.03 better than the analyst estimate of $0.75. Revenue for the quarter came in at $1.17 billion versus the consensus estimate of $1.18 billion.

"Our teams are doing an extraordinary job in managing through the COVID-19 pandemic," said President and Chief Executive Officer of Encompass Health Mark Tarr. "Our volumes recovered substantially in the third quarter, and we remain confident in the longer-term outlook for our company."

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.